Skip to main content
. 2023 Nov 10;18:350. doi: 10.1186/s13023-023-02962-5

Fig. 1.

Fig. 1

Geographic distribution of all patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS)